F4
Form 4
AI
Filings
Pricing
Sign in
Issuer · CIK 0001821586
MLTX — MoonLake Immunotherapeutics
Recent filings
May 13, 2026
·
Form 4
·
Sell
$273.3K
MLTX
/
MoonLake Immunotherapeutics
Bodenstedt Matthias · Chief Financial Officer
28
conviction
← Back to all filings